Publications & Reports

2024

Association of HBV treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study. (Makuza J.D., et al.)
August 2024 |Lancet Regional Health – Americas | Available online: here

Hepatitis C virus: cascade of care in infants and children. (Sauvé L., et al.)
August 2024 |UBC Continuing Professional Development | Available online: here

Impact of COVID-19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: an interrupted time series study.  (Makuza J.D., et al.)
June 2024|Journal of Viral Hepatitis | Available online: here

Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada. (Greenwald Z.R., et al.)
June 2024 |Journal of Clinical Epidemiology | Available online: here

Impact of the COVID-19 pandemic on hepatitis C treatment initiation in British Columbia, Canada: an interrupted time series study. (Morrow R., et al.)
April 2024 |Viruses | Available online: here

“Shared experience makes this all possible”: documenting the guiding principles of peer-led services for people released from prison. (Palis H., et al.)
January 2024 | BMC Public Health | Available online: here

2023

Progress Towards Viral Hepatitis Elimination In Canada 2023 Report (Action Hepatitis Canada)
2023 | Action Hepatitis Canada  | Available online: here

Test Link Call Project Impact Evaluation Report 2021-2022. (Gale, N., Tiwana, A., & Bartlett, S.R).
2023 | BC Centre for Disease Control  | Available online: here

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada (Jeong D., et al.)
December 2023 | Lancet Regional Health Americas | Available online: here

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada (Reddon H, et al.)
October 2023 | Scientific Reports | Available online: here

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study (Hamill V, et al.)
August 2023 | British Medical Journal | Available online: here

Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study (Snell G, et al.)
July 2023 | Canadian Liver Journal  | Available online: here

Expanding access to hepatitis C prevention, testing, and treatment in prisons: Recommendations from the INHSU 2022 Prisons Workshop. (Coalition for Global Hepatitis Elimination and INHSU Prisons)
2023 | The Task Force for Global Health | Available online: here

2022

Prison Health Is Public Health: The Right to Hepatitis C Prevention, Diagnosis, and Care in Canada’s Correctional Settings (Action Hepatitis Canada)
2022 | Action Hepatitis Canada  | Available online: here

Sexually transmitted and blood-borne infection testing and linkage to care during incarceration: There’s no time like the prison time! (Bartlett et al.)
2022 | University of British Columbia Medical Journal | Available online: here

Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study. (Makuza J.D., et al.)
November 2022 | Viruses | Available online: here

Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort.. (Darvishian M., et al.)
October 2022 | Frontiers in Oncology 2022 | Available online: here

The Impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from the direct-acting antiviral (DAA) era: A population-based study (Bartlett et al.)
February 2022 | Clinical Infectious Diseases | Available online: here

It is Time for Us All to Embrace Person-Centred Language for People in Prison and People Who were Formerly in Prison (Harney et al.)
January 2022 | International Journal of Drug Policy | Available online: here | Lay Summary: here

2021

“They look at you like you’re contaminated”: how HIV-related stigma shapes access to care for incarcerated women living with HIV in a Canadian setting (Erickson et al.)
September 2021 | Canadian Journal of Public Health | Abstract available online: here

Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination (Kronfli et al.)
June 2021 | Canadian Liver Journal | Available online: here

Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era (Bartlett et al.)
February 2021 | Clinical Liver Disease | Available online: here

“The Times They Are a-Changin’”: Addressing Common Misconceptions About the Role of Safe Supply in North America’s Overdose Crisis (Bonn et al.)
February 2021 | Journal of Studies on Alcohol and Drugs | Available online: here

2020

Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada (Samji et al.)
December 2020 | International Journal of Drug Policy | Available online: here

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply (Bonn et al.)
October | Journal of studies on alcohol and drugs | Available online: here

2019

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals (Bartlett et al.)
August 2019 | Liver International | Available online: here

2018

Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project (Bartlett et al.)
August 2018 | Clinical Infectious Diseases | Available online: here